STRECK PAUL 4

What Happened
Paul Streck, EVP and Head of R&D at PepGen (PEPG), had 1,879 shares sold on his behalf on March 4, 2026. The sales consisted of 1,832 shares at $6.23 ($11,413) and 47 shares at $6.29 ($296), for a total of roughly $11,709. These were sales (not purchases) and reflect a routine tax-withholding action tied to RSU vesting, not an exercise of bullish conviction.

Key Details

• Transaction dates & prices: 2026-03-04 — 1,832 sh @ $6.23; 47 sh @ $6.29.
• Total shares sold: 1,879; total proceeds ≈ $11,709.
• Shares owned after transaction: Not reported in the provided filing excerpt.
• Footnote: Sales were automatic sell-to-cover transactions executed by the company to satisfy minimum statutory tax withholding on vested RSUs. The RSU agreement provided for the mandatory sale and the filing notes this was not a discretionary trade (consistent with a binding contract / 10b5-1 affirmative defense).
• Filing: Report filed 2026-03-06 for transactions on 2026-03-04; appears to be timely (Form 4s are generally due within two business days).

Context
This was a tax-withholding sale tied to RSU vesting — a common, routine event that does not necessarily indicate the insider's view on the company's outlook. Retail investors often weigh purchases more heavily than routine sell-to-cover transactions when assessing insider sentiment.